Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
13.56
+0.42 (+3.20%)
Range 13.22 - 13.62
Open 13.32
Prev Close 13.14
52 Week 7.65 - 15.79
Volume 516137
Market Cap 1.41B
*Delayed 6/28/2016 4:00 EDT

 
Form 8937 for 2015 Reverse Stock Split

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000